BtH Body 2.2% Injectable Hyaluronic Acid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BtH Body 2.2% Injectable Hyaluronic Acid, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of BtH Body 2.2% (Injectable Hyaluronic Acid) in Volumizing and Contouring Large Areas of the Body: Prospective Clinical Investigation. [NA]